[PHARMA] QoQ TTM Result on 31-Dec-2010 [#4]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
25-Feb-2011
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2010
Quarter
31-Dec-2010 [#4]
Profit Trend
QoQ- -44.3%
YoY- -49.52%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 CAGR
Revenue 1,529,311 1,492,216 1,446,116 1,378,348 1,326,138 1,321,763 1,304,640 11.16%
PBT 54,117 53,876 54,823 45,462 75,653 69,675 73,685 -18.58%
Tax -15,466 -17,749 -18,223 -15,152 -21,273 -17,335 -17,340 -7.33%
NP 38,651 36,127 36,600 30,310 54,380 52,340 56,345 -22.20%
-
NP to SH 37,959 35,734 36,561 30,384 54,554 52,027 54,977 -21.86%
-
Tax Rate 28.58% 32.94% 33.24% 33.33% 28.12% 24.88% 23.53% -
Total Cost 1,490,660 1,456,089 1,409,516 1,348,038 1,271,758 1,269,423 1,248,295 12.54%
-
Net Worth 464,092 451,517 437,661 421,262 424,488 417,065 439,675 3.66%
Dividend
30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 CAGR
Div - - 50,261 50,261 89,852 118,755 97,382 -
Div Payout % - - 137.47% 165.42% 164.70% 228.26% 177.13% -
Equity
30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 CAGR
Net Worth 464,092 451,517 437,661 421,262 424,488 417,065 439,675 3.66%
NOSH 106,933 106,994 107,007 106,919 106,924 106,939 106,977 -0.02%
Ratio Analysis
30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 CAGR
NP Margin 2.53% 2.42% 2.53% 2.20% 4.10% 3.96% 4.32% -
ROE 8.18% 7.91% 8.35% 7.21% 12.85% 12.47% 12.50% -
Per Share
30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 CAGR
RPS 1,430.15 1,394.66 1,351.41 1,289.15 1,240.26 1,235.99 1,219.55 11.19%
EPS 35.50 33.40 34.17 28.42 51.02 48.65 51.39 -21.83%
DPS 0.00 0.00 47.00 47.00 84.00 111.00 91.00 -
NAPS 4.34 4.22 4.09 3.94 3.97 3.90 4.11 3.69%
Adjusted Per Share Value based on latest NOSH - 106,919
30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 CAGR
RPS 106.11 103.54 100.34 95.64 92.01 91.71 90.52 11.16%
EPS 2.63 2.48 2.54 2.11 3.79 3.61 3.81 -21.87%
DPS 0.00 0.00 3.49 3.49 6.23 8.24 6.76 -
NAPS 0.322 0.3133 0.3037 0.2923 0.2945 0.2894 0.3051 3.65%
Price Multiplier on Financial Quarter End Date
30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 CAGR
Date 30/09/11 30/06/11 31/03/11 30/12/10 30/09/10 30/06/10 31/03/10 -
Price 5.90 5.90 5.73 5.31 4.98 4.98 4.27 -
P/RPS 0.41 0.42 0.42 0.41 0.40 0.40 0.35 11.11%
P/EPS 16.62 17.67 16.77 18.69 9.76 10.24 8.31 58.67%
EY 6.02 5.66 5.96 5.35 10.25 9.77 12.04 -36.97%
DY 0.00 0.00 8.20 8.85 16.87 22.29 21.31 -
P/NAPS 1.36 1.40 1.40 1.35 1.25 1.28 1.04 19.56%
Price Multiplier on Announcement Date
30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 CAGR
Date 01/11/11 10/08/11 13/05/11 25/02/11 04/11/10 11/08/10 26/05/10 -
Price 5.90 5.90 5.05 5.35 4.92 4.95 4.71 -
P/RPS 0.41 0.42 0.37 0.42 0.40 0.40 0.39 3.38%
P/EPS 16.62 17.67 14.78 18.83 9.64 10.17 9.16 48.70%
EY 6.02 5.66 6.77 5.31 10.37 9.83 10.91 -32.70%
DY 0.00 0.00 9.31 8.79 17.07 22.42 19.32 -
P/NAPS 1.36 1.40 1.23 1.36 1.24 1.27 1.15 11.81%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment